Prospera Financial Services Inc reduced its stake in MetLife, Inc. (NYSE:MET - Free Report) by 94.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,475 shares of the financial services provider's stock after selling 58,425 shares during the period. Prospera Financial Services Inc's holdings in MetLife were worth $287,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of MET. Verity & Verity LLC raised its stake in MetLife by 2.0% in the third quarter. Verity & Verity LLC now owns 228,570 shares of the financial services provider's stock valued at $18,852,000 after buying an additional 4,452 shares in the last quarter. Meeder Asset Management Inc. raised its position in shares of MetLife by 48,101.4% during the 3rd quarter. Meeder Asset Management Inc. now owns 106,043 shares of the financial services provider's stock worth $8,746,000 after acquiring an additional 105,823 shares in the last quarter. Cassaday & Co Wealth Management LLC purchased a new stake in MetLife during the third quarter worth approximately $229,000. Quest Partners LLC boosted its holdings in MetLife by 299,333.3% in the third quarter. Quest Partners LLC now owns 8,983 shares of the financial services provider's stock valued at $741,000 after purchasing an additional 8,980 shares in the last quarter. Finally, TrinityPoint Wealth LLC purchased a new position in MetLife in the third quarter valued at approximately $237,000. 89.81% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Price Performance
MetLife stock traded up $0.77 during trading hours on Monday, hitting $87.36. The stock had a trading volume of 4,118,739 shares, compared to its average volume of 3,321,367. The stock has a market capitalization of $60.49 billion, a price-to-earnings ratio of 17.46, a PEG ratio of 0.79 and a beta of 1.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1-year low of $62.81 and a 1-year high of $87.64. The stock's fifty day moving average is $82.48 and its two-hundred day moving average is $76.08.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be issued a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.50%. The ex-dividend date is Tuesday, November 5th. MetLife's dividend payout ratio (DPR) is presently 43.95%.
Wall Street Analyst Weigh In
MET has been the topic of several research analyst reports. Barclays cut their price target on shares of MetLife from $91.00 to $90.00 and set an "overweight" rating on the stock in a research note on Thursday, October 31st. StockNews.com raised MetLife from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th. TD Cowen started coverage on MetLife in a research report on Wednesday, October 9th. They set a "buy" rating and a $97.00 price target on the stock. Piper Sandler increased their price objective on MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a report on Wednesday, October 2nd. Finally, Wells Fargo & Company raised their target price on shares of MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 5th. Fourteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, MetLife has a consensus rating of "Buy" and an average target price of $88.46.
Read Our Latest Analysis on MetLife
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
